sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Europe Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Country: Trend Forecast and Growth Opportunity

Europe Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API,...

Home / Categories / Healthcare
Europe Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Country: Trend Forecast and Growth Opportunity
Europe Pharmaceutical Contract Manufacturing Market...
Report Code
RO1/105/1064

Publish Date
26/Oct/2020

Pages
116
PRICE
$ 3000/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4300/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5600/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Europe pharmaceutical contract manufacturing market accounted for $24.4 billion in 2019 and will grow by 6.0% annually over 2020-2030 owing to the rising need for medicines amid COVID-19 pandemic and increasing dependence on contract manufacturing organizations due to improved efficiency and productivity.
Highlighted with 38 tables and 53 figures, this 116-page report "Europe Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Europe pharmaceutical contract manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical contract manufacturing market in every aspect of the classification from perspectives of Category, Product, Phase, Type, Therapeutic Application, and Country.

Based on Category, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Pharmaceutical Industry
- Biopharmaceutical Industry

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Active Pharmaceutical Ingredients (API)
- Branded API Manufacturing
- Generic API Manufacturing
Finished Dosage Formulations (FDF)
- Solid Dosage
- Oral Liquids
- Parenteral/Injectables
- Other FDFs
Secondary Packaging

Based on Phase, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Clinical Manufacturing
- Commercial Manufacturing

Based on Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Sterile Products
- Non-Sterile Products

Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Infectious Diseases
- Oncology
- Metabolic Disorders
- Cardiovascular Disorders
- Central Nervous System
- Pulmonary Disorders
- Gastrointestinal Disorders
- Other Therapeutic Applications

Geographically, the following national/local markets are fully investigated:
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product, Phase, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe pharmaceutical contract manufacturing market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Aenova Group
Baxter BioPharma Solutions
Boehringer Ingelheim
Catalent Inc.
Famar S.A.
Hospira, Inc.
Jubilant Life Sciences Ltd.
Lonza Group
Patheon Inc.
Pfizer CentreSource
Recipharm AB
Vetter Pharma International GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com